Lundbeck takes risk on Parkinson’s treatment, €905m on table
March 19, 2018Sales and Marketing Lundbeck, Parkinson's, biotech, drugs, pharma, pharmaceutical
CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take …
India’s Narcotics Control Bureau seizes 55,000 zolpidem tablets in drugs bust
March 19, 2018Manufacturing and Production, Sales and Marketing India, Narcotics Control Bureau, pharma
India’s drug agency, the Narcotics Control Bureau (NCB), has shut down an illegal trafficking racket in the country in a …
Pfizer to hang onto CEO, after 61% pay increase
March 19, 2018Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …
Top Ten most popular articles on Pharmafile.com this week
March 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten
Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …
Rising levels of opioid prescriptions puts NHS under pressure
March 16, 2018Medical Communications NHS, biotech, drugs, opioid, pharma, pharmaceutical
It has been found that the number of prescriptions being written for opioid painkillers has risen from 10 million to …
NICE recommends Keytruda via CDF as first and only urothelial carcinoma immunotherapy
March 16, 2018Medical Communications, Sales and Marketing MSD, NICE, immunotherapy, keytruda, pharma
UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through …
Allergan navigating choppy waters, as shares rise and fall
March 16, 2018Medical Communications Allergan, Brent Saunders, biotech, drugs, pharma, pharmaceutical
By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative …
Hearing drug failure puts biotech on brink
March 16, 2018Medical Communications, Research and Development Auris, biotech, drugs, pharma, pharmaceutical
Biotechs with few products in the portfolio are always at a risk should results come back flat, it often leads …
The need for flexible appraisal of rare disease medicines
March 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, feature, pharma, rare disease, rare diseases
Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal …
BMS restructure will transfer 90 jobs from NY state to Massachusetts and New Jersey
March 15, 2018Manufacturing and Production BMS, Bristol-Myers Squibb, Massachusetts, New York, new jersey, pharma
Bristol-Myers Squibb has announced plans to relocate around 90 roles from the state of New York to facilities in Massachusetts …
Solid Biosciences rocked by clinical hold, shareholders flee
March 15, 2018Research and Development Solid Biosciences, biotech, drugs, pharma, pharmaceutical
Solid Biosciences raised more than a few eyebrows when it only revealed a partial hold from the FDA stalling its …
Roche appoints new research and early development head
March 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, appointment
Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …
Fat-fighting pharma business files for bankruptcy
March 15, 2018Sales and Marketing Contrave, biotech, drugs, orexigen, pharma, pharmaceutical
Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it …
Andrew Witty takes on a new CEO position
March 15, 2018Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical
Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …
Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe
March 15, 2018Medical Communications biotech, drugs, pharma, pharmaceutical, veeva
Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …
Takeda’s CFO departs forcing company to act
March 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical
Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …
Teva denies wrongdoing in Cephalon pay-to-delay deal hearing
March 14, 2018Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma
Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …
Hammond suggests NHS may receive cash boost
March 14, 2018Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical
The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …
US “right to try” experimental drug bill defeated in House vote
March 14, 2018Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma
The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …
World’s first synthetic, non-biologic vaccine developed
March 14, 2018Research and Development Vaccine, biotech, drugs, influenza, pharma, pharmaceutical
One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
